Monte Carlo Optimization Method Based QSAR Modeling of Placental Barrier Permeability
Purpose In order to ensure that drug administration is safe during pregnancy, it is crucial to have the possibility to predict the placental permeability of drugs in humans. The experimental method which is most widely used for the said purpose is in vitro human placental perfusion, though the appro...
Gespeichert in:
Veröffentlicht in: | Pharmaceutical research 2024-03, Vol.41 (3), p.493-500 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 500 |
---|---|
container_issue | 3 |
container_start_page | 493 |
container_title | Pharmaceutical research |
container_volume | 41 |
creator | Vukomanović, Predrag Stefanović, Milan Stevanović, Jelena Milošević Petrić, Aleksandra Trenkić, Milan Andrejević, Lazar Lazarević, Milan Sokolović, Danka Veselinović, Aleksandar M. |
description | Purpose
In order to ensure that drug administration is safe during pregnancy, it is crucial to have the possibility to predict the placental permeability of drugs in humans. The experimental method which is most widely used for the said purpose is
in vitro
human placental perfusion, though the approach is highly expensive and time consuming. Quantitative structure–activity relationship (QSAR) modeling represents a powerful tool for the assessment of the drug placental transfer, and can be successfully employed to be an alternative in
in vitro
experiments.
Methods
The conformation-independent QSAR models covered in the present study were developed through the use of the SMILES notation descriptors and local molecular graph invariants. What is more, the Monte Carlo optimization method, was used in the test sets and the training sets as the model developer with three independent molecular splits.
Results
A range of different statistical parameters was used to validate the developed QSAR model, including the standard error of estimation, mean absolute error, root-mean-square error (RMSE), correlation coefficient, cross-validated correlation coefficient, Fisher ratio, MAE-based metrics and the correlation ideality index. Once the mentioned statistical methods were employed, an excellent predictive potential and robustness of the developed QSAR model was demonstrated. In addition, the molecular fragments, which are derived from the SMILES notation descriptors accounting for the decrease or increase in the investigated activity, were revealed.
Conclusion
The presented QSAR modeling can be an invaluable tool for the high-throughput screening of the placental permeability of drugs. |
doi_str_mv | 10.1007/s11095-024-03675-5 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2925034278</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2925034278</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-ed3a0da086f1558f678347aaf51ff0493ddf4a161b63ca0f614a4f44c16fef13</originalsourceid><addsrcrecordid>eNp9kMFu1DAQhq2qqLvd8gIckKVeuKTMxHacHMsKClJXLaVI3CxvMl5cJfHWzh6Wp8ewLUgcOM1hvv-f0cfYK4QLBNBvEyI0qoBSFiAqrQp1xOaotCgakN-O2Rx0XtVa4oydpvQAADU28oTNRC2ERlBz9nUVxon40sY-8Jvt5Af_w04-jHxF0_fQ8Xc2Ucc_f7m846vQUe_HDQ-O3_a2pXGyfQZi9BT5LcWB7Nr3ftqfsRfO9olePs0Fu__w_n75sbi-ufq0vLwuWqHVVFAnLHQW6sqhUrWrdC2kttYpdA5kI7rOSYsVrivRWnAVSiudlC1WjhyKBXtzqN3G8LijNJnBp5b63o4UdsmUTalAyDLXLtj5P-hD2MUxP5cppRBV3YhMlQeqjSGlSM5sox9s3BsE88u5OTg32bn57dyoHHr9VL1bD9T9iTxLzoA4ACmvxg3Fv7f_U_sTJpGLgA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2955115893</pqid></control><display><type>article</type><title>Monte Carlo Optimization Method Based QSAR Modeling of Placental Barrier Permeability</title><source>SpringerLink Journals</source><creator>Vukomanović, Predrag ; Stefanović, Milan ; Stevanović, Jelena Milošević ; Petrić, Aleksandra ; Trenkić, Milan ; Andrejević, Lazar ; Lazarević, Milan ; Sokolović, Danka ; Veselinović, Aleksandar M.</creator><creatorcontrib>Vukomanović, Predrag ; Stefanović, Milan ; Stevanović, Jelena Milošević ; Petrić, Aleksandra ; Trenkić, Milan ; Andrejević, Lazar ; Lazarević, Milan ; Sokolović, Danka ; Veselinović, Aleksandar M.</creatorcontrib><description>Purpose
In order to ensure that drug administration is safe during pregnancy, it is crucial to have the possibility to predict the placental permeability of drugs in humans. The experimental method which is most widely used for the said purpose is
in vitro
human placental perfusion, though the approach is highly expensive and time consuming. Quantitative structure–activity relationship (QSAR) modeling represents a powerful tool for the assessment of the drug placental transfer, and can be successfully employed to be an alternative in
in vitro
experiments.
Methods
The conformation-independent QSAR models covered in the present study were developed through the use of the SMILES notation descriptors and local molecular graph invariants. What is more, the Monte Carlo optimization method, was used in the test sets and the training sets as the model developer with three independent molecular splits.
Results
A range of different statistical parameters was used to validate the developed QSAR model, including the standard error of estimation, mean absolute error, root-mean-square error (RMSE), correlation coefficient, cross-validated correlation coefficient, Fisher ratio, MAE-based metrics and the correlation ideality index. Once the mentioned statistical methods were employed, an excellent predictive potential and robustness of the developed QSAR model was demonstrated. In addition, the molecular fragments, which are derived from the SMILES notation descriptors accounting for the decrease or increase in the investigated activity, were revealed.
Conclusion
The presented QSAR modeling can be an invaluable tool for the high-throughput screening of the placental permeability of drugs.</description><identifier>ISSN: 0724-8741</identifier><identifier>EISSN: 1573-904X</identifier><identifier>DOI: 10.1007/s11095-024-03675-5</identifier><identifier>PMID: 38337105</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Biochemistry ; Biomedical and Life Sciences ; Biomedical Engineering and Bioengineering ; Biomedicine ; Conformation ; High-throughput screening ; Medical Law ; Original Research Article ; Permeability ; Pharmacology/Toxicology ; Pharmacy ; Placenta ; Placental transfer ; Statistics ; Structure-activity relationships</subject><ispartof>Pharmaceutical research, 2024-03, Vol.41 (3), p.493-500</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-ed3a0da086f1558f678347aaf51ff0493ddf4a161b63ca0f614a4f44c16fef13</citedby><cites>FETCH-LOGICAL-c375t-ed3a0da086f1558f678347aaf51ff0493ddf4a161b63ca0f614a4f44c16fef13</cites><orcidid>0000-0001-9291-6654</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11095-024-03675-5$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11095-024-03675-5$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38337105$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vukomanović, Predrag</creatorcontrib><creatorcontrib>Stefanović, Milan</creatorcontrib><creatorcontrib>Stevanović, Jelena Milošević</creatorcontrib><creatorcontrib>Petrić, Aleksandra</creatorcontrib><creatorcontrib>Trenkić, Milan</creatorcontrib><creatorcontrib>Andrejević, Lazar</creatorcontrib><creatorcontrib>Lazarević, Milan</creatorcontrib><creatorcontrib>Sokolović, Danka</creatorcontrib><creatorcontrib>Veselinović, Aleksandar M.</creatorcontrib><title>Monte Carlo Optimization Method Based QSAR Modeling of Placental Barrier Permeability</title><title>Pharmaceutical research</title><addtitle>Pharm Res</addtitle><addtitle>Pharm Res</addtitle><description>Purpose
In order to ensure that drug administration is safe during pregnancy, it is crucial to have the possibility to predict the placental permeability of drugs in humans. The experimental method which is most widely used for the said purpose is
in vitro
human placental perfusion, though the approach is highly expensive and time consuming. Quantitative structure–activity relationship (QSAR) modeling represents a powerful tool for the assessment of the drug placental transfer, and can be successfully employed to be an alternative in
in vitro
experiments.
Methods
The conformation-independent QSAR models covered in the present study were developed through the use of the SMILES notation descriptors and local molecular graph invariants. What is more, the Monte Carlo optimization method, was used in the test sets and the training sets as the model developer with three independent molecular splits.
Results
A range of different statistical parameters was used to validate the developed QSAR model, including the standard error of estimation, mean absolute error, root-mean-square error (RMSE), correlation coefficient, cross-validated correlation coefficient, Fisher ratio, MAE-based metrics and the correlation ideality index. Once the mentioned statistical methods were employed, an excellent predictive potential and robustness of the developed QSAR model was demonstrated. In addition, the molecular fragments, which are derived from the SMILES notation descriptors accounting for the decrease or increase in the investigated activity, were revealed.
Conclusion
The presented QSAR modeling can be an invaluable tool for the high-throughput screening of the placental permeability of drugs.</description><subject>Biochemistry</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedical Engineering and Bioengineering</subject><subject>Biomedicine</subject><subject>Conformation</subject><subject>High-throughput screening</subject><subject>Medical Law</subject><subject>Original Research Article</subject><subject>Permeability</subject><subject>Pharmacology/Toxicology</subject><subject>Pharmacy</subject><subject>Placenta</subject><subject>Placental transfer</subject><subject>Statistics</subject><subject>Structure-activity relationships</subject><issn>0724-8741</issn><issn>1573-904X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kMFu1DAQhq2qqLvd8gIckKVeuKTMxHacHMsKClJXLaVI3CxvMl5cJfHWzh6Wp8ewLUgcOM1hvv-f0cfYK4QLBNBvEyI0qoBSFiAqrQp1xOaotCgakN-O2Rx0XtVa4oydpvQAADU28oTNRC2ERlBz9nUVxon40sY-8Jvt5Af_w04-jHxF0_fQ8Xc2Ucc_f7m846vQUe_HDQ-O3_a2pXGyfQZi9BT5LcWB7Nr3ftqfsRfO9olePs0Fu__w_n75sbi-ufq0vLwuWqHVVFAnLHQW6sqhUrWrdC2kttYpdA5kI7rOSYsVrivRWnAVSiudlC1WjhyKBXtzqN3G8LijNJnBp5b63o4UdsmUTalAyDLXLtj5P-hD2MUxP5cppRBV3YhMlQeqjSGlSM5sox9s3BsE88u5OTg32bn57dyoHHr9VL1bD9T9iTxLzoA4ACmvxg3Fv7f_U_sTJpGLgA</recordid><startdate>20240301</startdate><enddate>20240301</enddate><creator>Vukomanović, Predrag</creator><creator>Stefanović, Milan</creator><creator>Stevanović, Jelena Milošević</creator><creator>Petrić, Aleksandra</creator><creator>Trenkić, Milan</creator><creator>Andrejević, Lazar</creator><creator>Lazarević, Milan</creator><creator>Sokolović, Danka</creator><creator>Veselinović, Aleksandar M.</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9291-6654</orcidid></search><sort><creationdate>20240301</creationdate><title>Monte Carlo Optimization Method Based QSAR Modeling of Placental Barrier Permeability</title><author>Vukomanović, Predrag ; Stefanović, Milan ; Stevanović, Jelena Milošević ; Petrić, Aleksandra ; Trenkić, Milan ; Andrejević, Lazar ; Lazarević, Milan ; Sokolović, Danka ; Veselinović, Aleksandar M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-ed3a0da086f1558f678347aaf51ff0493ddf4a161b63ca0f614a4f44c16fef13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Biochemistry</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedical Engineering and Bioengineering</topic><topic>Biomedicine</topic><topic>Conformation</topic><topic>High-throughput screening</topic><topic>Medical Law</topic><topic>Original Research Article</topic><topic>Permeability</topic><topic>Pharmacology/Toxicology</topic><topic>Pharmacy</topic><topic>Placenta</topic><topic>Placental transfer</topic><topic>Statistics</topic><topic>Structure-activity relationships</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vukomanović, Predrag</creatorcontrib><creatorcontrib>Stefanović, Milan</creatorcontrib><creatorcontrib>Stevanović, Jelena Milošević</creatorcontrib><creatorcontrib>Petrić, Aleksandra</creatorcontrib><creatorcontrib>Trenkić, Milan</creatorcontrib><creatorcontrib>Andrejević, Lazar</creatorcontrib><creatorcontrib>Lazarević, Milan</creatorcontrib><creatorcontrib>Sokolović, Danka</creatorcontrib><creatorcontrib>Veselinović, Aleksandar M.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmaceutical research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vukomanović, Predrag</au><au>Stefanović, Milan</au><au>Stevanović, Jelena Milošević</au><au>Petrić, Aleksandra</au><au>Trenkić, Milan</au><au>Andrejević, Lazar</au><au>Lazarević, Milan</au><au>Sokolović, Danka</au><au>Veselinović, Aleksandar M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Monte Carlo Optimization Method Based QSAR Modeling of Placental Barrier Permeability</atitle><jtitle>Pharmaceutical research</jtitle><stitle>Pharm Res</stitle><addtitle>Pharm Res</addtitle><date>2024-03-01</date><risdate>2024</risdate><volume>41</volume><issue>3</issue><spage>493</spage><epage>500</epage><pages>493-500</pages><issn>0724-8741</issn><eissn>1573-904X</eissn><abstract>Purpose
In order to ensure that drug administration is safe during pregnancy, it is crucial to have the possibility to predict the placental permeability of drugs in humans. The experimental method which is most widely used for the said purpose is
in vitro
human placental perfusion, though the approach is highly expensive and time consuming. Quantitative structure–activity relationship (QSAR) modeling represents a powerful tool for the assessment of the drug placental transfer, and can be successfully employed to be an alternative in
in vitro
experiments.
Methods
The conformation-independent QSAR models covered in the present study were developed through the use of the SMILES notation descriptors and local molecular graph invariants. What is more, the Monte Carlo optimization method, was used in the test sets and the training sets as the model developer with three independent molecular splits.
Results
A range of different statistical parameters was used to validate the developed QSAR model, including the standard error of estimation, mean absolute error, root-mean-square error (RMSE), correlation coefficient, cross-validated correlation coefficient, Fisher ratio, MAE-based metrics and the correlation ideality index. Once the mentioned statistical methods were employed, an excellent predictive potential and robustness of the developed QSAR model was demonstrated. In addition, the molecular fragments, which are derived from the SMILES notation descriptors accounting for the decrease or increase in the investigated activity, were revealed.
Conclusion
The presented QSAR modeling can be an invaluable tool for the high-throughput screening of the placental permeability of drugs.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>38337105</pmid><doi>10.1007/s11095-024-03675-5</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0001-9291-6654</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0724-8741 |
ispartof | Pharmaceutical research, 2024-03, Vol.41 (3), p.493-500 |
issn | 0724-8741 1573-904X |
language | eng |
recordid | cdi_proquest_miscellaneous_2925034278 |
source | SpringerLink Journals |
subjects | Biochemistry Biomedical and Life Sciences Biomedical Engineering and Bioengineering Biomedicine Conformation High-throughput screening Medical Law Original Research Article Permeability Pharmacology/Toxicology Pharmacy Placenta Placental transfer Statistics Structure-activity relationships |
title | Monte Carlo Optimization Method Based QSAR Modeling of Placental Barrier Permeability |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T23%3A33%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Monte%20Carlo%20Optimization%20Method%20Based%20QSAR%20Modeling%20of%20Placental%20Barrier%20Permeability&rft.jtitle=Pharmaceutical%20research&rft.au=Vukomanovi%C4%87,%20Predrag&rft.date=2024-03-01&rft.volume=41&rft.issue=3&rft.spage=493&rft.epage=500&rft.pages=493-500&rft.issn=0724-8741&rft.eissn=1573-904X&rft_id=info:doi/10.1007/s11095-024-03675-5&rft_dat=%3Cproquest_cross%3E2925034278%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2955115893&rft_id=info:pmid/38337105&rfr_iscdi=true |